C1ORF55 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.051400E-01
Normal-vs-Stage2
9.491000E-01
Normal-vs-Stage3
2.511200E-01
Normal-vs-Stage4
1.688030E-01
Stage1-vs-Stage2
5.165800E-01
Stage1-vs-Stage3
9.628400E-02
Stage1-vs-Stage4
1.325750E-01
Stage2-vs-Stage3
1.810770E-01
Stage2-vs-Stage4
9.140600E-03
Stage3-vs-Stage4
2.577600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.171600E-01
Normal-vs-AfricanAmerican
5.198600E-01
Normal-vs-Asian
7.377200E-01
Caucasian-vs-AfricanAmerican
1.956850E-01
Caucasian-vs-Asian
5.939600E-01
AfricanAmerican-vs-Asian
2.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.544400E-01
Normal-vs-Female
9.405000E-01
Male-vs-Female
9.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.789600E-01
Normal-vs-Age(41-60Yrs)
7.648600E-01
Normal-vs-Age(61-80Yrs)
8.285800E-01
Normal-vs-Age(81-100Yrs)
4.930600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.163400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.602600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.254400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.131500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.275170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.100200E-01
Normal-vs-Daily Drinker
3.678800E-01
Normal-vs-Weekly Drinker
8.948800E-01
Normal-vs-Occasional Drinker
6.407800E-01
Normal-vs-Social Drinker
8.402200E-01
Non Drinker-vs-Daily Drinker
1.768020E-01
Non Drinker-vs-Weekly Drinker
9.220000E-01
Non Drinker-vs-Occasional Drinker
1.376590E-01
Non Drinker-vs-Social Drinker
9.935200E-01
Daily Drinker-vs-Weekly Drinker
2.828800E-01
Daily Drinker-vs-Occasional Drinker
1.325760E-02
Daily Drinker-vs-Social Drinker
2.729200E-01
Weekly Drinker-vs-Occasional Drinker
3.209400E-01
Weekly Drinker-vs-Social Drinker
9.430400E-01
Occasional Drinker-vs-Social Drinker
2.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.523600E-02
Normal-vs-Grade 2
2.047900E-02
Normal-vs-Grade 3
2.191500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.612650E-01
Grade 1-vs-Grade 3
1.285210E-01
Grade 1-vs-Grade 4
8.523600E-02
Grade 2-vs-Grade 3
6.774400E-01
Grade 2-vs-Grade 4
2.047900E-02
Grade 3-vs-Grade 4
2.191500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.628400E-01
Normal-vs-NonDiabetic
7.982400E-01
Diabetic-vs-NonDiabetic
8.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.614200E-01
Normal-vs-NoPancreatitis
8.773200E-01
Pancreatitis-vs-NoPancreatitis
2.950400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.297200E-01
Normal-vs-N1
9.738800E-01
N0-vs-N1
8.541400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.732600E-01
Normal-vs-TP53-NonMutant
9.018600E-01
TP53-Mutant-vs-TP53-NonMutant
3.376200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
